• Publication & Reference: Erratum to: 'Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance' (J Hepatol 2019; 71(1): 14-24). J Hepatol. 2020;73(4):999-1000.
  • DOI: 10.1016/j.jhep.2020.07.004
  • Author(s): Merat SJ, Bru C, van de Berg D, Molenkamp R, Tarr AW, Koekkoek S, et al.
Research Theme | Gastrointestinal & Liver

Publication & Reference

Erratum to: 'Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance' (J Hepatol 2019; 71(1): 14-24). J Hepatol. 2020;73(4):999-1000.

DOI

10.1016/j.jhep.2020.07.004

Author(s)

Merat SJ, Bru C, van de Berg D, Molenkamp R, Tarr AW, Koekkoek S, et al.
Back to all publications

Contact Us

NIHR Biomedical Research Centre: Nottingham
Research & Innovation
D Floor (via South Block)
Nottingham University Hospitals NHS Trust
Queen’s Medical Centre
Derby Road
Nottingham
NG7 2UH

Telephone: 0115 924 9924

Director: Professor Ian Hall

Hosted by

Nottingham University Hospitals Logo

Nottingham University Hospitals Logo

We are a partnership between Nottingham University Hospitals NHS Trust and the University of Nottingham, supported by NHS and academic partners in Nottingham and across the East Midlands.

Website by Volute